NCR3 and Behcet disease: Neither the classification of BD patients based on BDCAF scores nor the classification according to the presence/absence of therapy showed any differences in the percentages of NK, NKT, and T cells expressing the CD69, CD16, Nkp30, Nkp46, and NKG2A surface markers (Figure S4, S5).